Friday January 15, 2021 21:13

Food and Healthcare Press Releases

Nonin Medical Announces New Full Board of Directors Heathcare—15 Jan 21

Nonin Medical announced the appointment of four new members to the company's board of directors. Each of the new directors brings unique industry experience and passion for innovation in the medtech and healthcare sectors. Together, they will provide

Medical Microinstruments Appoints Healthcare Industry Veteran Mark Toland as Chief Executive Heathcare—14 Jan 21

Toland joins Andrew Cleeland (Chairman of the Board, MMI) in developing the field of robotic-assisted microsurgery Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery,

Caliber Ophthalmics Opens New State-of-the-Art Ophthalmology Center of Heathcare—14 Jan 21

Caliber Ophthalmics, a Surgical Specialties Corporation company, is pleased to announce the opening of a state of the art ophthalmology design and manufacturing Center of Excellence in Sinking Spring, PA. The newly renovated 23,000 square foot facility

Guide Sensmart Launches New Guide QT Series IR Fever Warning System for Temperature Measurement Heathcare—13 Jan 21

As the COVID-19 global pandemic continues to rattle the world, accurate temperature measurement remains the most critical prevention and control measure used on the front line. On December 28, 2020, China's leading company in epidemic prevention and

deCODE genetics: Monozygous but not identical Heathcare—08 Jan 21

By sequencing the germline genomes of twins and comparing them to those of close relatives, scientists at deCODE genetics found mutations that are present in just one of the monozygotic twins and traced them back to the first days after conception. In

Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Heathcare—07 Jan 21

- Adds to Merck's lipid manufacturing expertise, providing an integrated offering across mRNA value chain - AmpTec's differentiated polymerase chain reaction (PCR)-based technology has shown to have advantages over other technologies for mRNA

Eleva Secures up to EUR 60 million to Advance a Drug Candidate, Appoints New Board Heathcare—06 Jan 21

Eleva, a manufacturer of superior biologics, has secured up to EUR 60 million in funding from Zukunftsfonds Heilbronn (ZFHN). The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further investment from venture

Gift of Life Donor Program Leads U.S. in Organ Donation for 13th Consecutive Heathcare—06 Jan 21

Region Demonstrates Extraordinary Generosity and Clinical Leadership Despite Pandemic Challenges: Most Organ Donors Every Year Since 2008 For the13thconsecutive year,Gift of Life Donor Program leads the nation in the most organ donors among all 58 U.S.

IP Key South-East Asia urges consumers to be aware of counterfeit cosmetics and beauty Heathcare—05 Jan 21

The second phase of IP Key SEA's #YourHealthIsPriceless campaign has been launched to raise awareness among consumers about the harm that counterfeit cosmetics can cause to their face, skin, and holistic well-being. Today, the IP Key South-East Asia

Bayer and the National Heart Centre Singapore Collaborate to Set Up Center of Excellence for Heathcare—05 Jan 21

Leveraging on Asian patient data, the 5-year collaboration aims to boost patient-centricity in R&D, leading to improved treatment outcomes in cardiovascular disease (CVD) management.The Center will generate and integrate high quality patient data

Cipla launches 'Covi-G' for COVID-19 rapid antibody detection Heathcare—28 Dec 20

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla") today announced that it signed a licensing agreement with a Belgium-based firm, Multi G for the distribution of their COVID-19 Rapid Antibody test kit, across most Emerging

จีน-ญี่ปุ่นกระชับความร่วมมือด้านสุขภาพ มุ่งส่งเสริมให้คนและโลกแข็งแรงขึ้น Heathcare—25 Dec 20

- การประชุม China-Japan Health Forum for the New Eraจัดโดย Global Health Forum of Boao Forum for Asia การประชุม China-Japan Health Forum for the New Era ซึ่งสนับสนุนโดย Global Health Forum of Boao Forum for Asia และ Nippon Global Medical Organization

Closer China-Japan Health Cooperation for Healthier Mankind and Healthier Heathcare—25 Dec 20

The China-Japan Health Forum for the New Era co-sponsored by Global Health Forum of Boao Forum for Asia and Nippon Global Medical Organization was held on December 22, 2020. Representatives of China and Japan including Chen Zhu, Vice Chairman of the

RedHill's Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Heathcare—23 Dec 20

Independent DSMB unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 based on review of unblinded safety data from 155 treated patients Top-line data from the 270-patient global Phase 2/3

Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Heathcare—21 Dec 20

Occlutech, a privately-held company, announced today that the US Food and Drug Administration (FDA) has granted the company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for Pulmonary Arterial

Small vessels can cause big problems; MagicTouch SCB Granted 'Breakthrough Device Designation' for Heathcare—18 Dec 20

Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for the MagicTouch SCB Sirolimus Coated Balloon Catheter, for the treatment

RedHill's Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-Related Blood Clotting in Preclinical Heathcare—18 Dec 20

Acute respiratory distress syndrome (ARDS)-induced thrombosis (blood clotting) may occur in up to one-third of COVID-19 patients requiring ICU admission and is a contributing cause of mortality Opaganib demonstrated reduced thrombosis in a preclinical

ADC Therapeutics และ Overland Pharma สร้างบริษัทร่วมทุนเชิงกลยุทธ์เพื่อขยายการพัฒนาและทำธุรกิจยา Heathcare—16 Dec 20

M.S.Q. Ventures ("MSQ") ยินดีที่จะประกาศว่า ADC Therapeutics SA (NYSE: ADCT) ซึ่งเป็นลูกค้าของบริษัท ประสบความสำเร็จในการเข้าร่วมข้อตกลงสร้างบริษัทใหม่ชื่อ Overland ADCT BioPharma (CY) Limited ร่วมกับ Overland Pharmaceuticals

TLCG organizes the "Innovations for Thai Lung Cancer Patients 2020" with the launch Heathcare—16 Dec 20

Thai Lung Cancer Group (TLCG) organizes the "Innovations for Thai Lung Cancer Patients 2020" event, bringing greater convenience to patients with the launch of a digital assistant "LungAndMe" Assoc. Prof. Dr. Virote Sriuranpong, M.D. (middle), Chairman

IP Key South-East Asia urges consumers to be aware of counterfeit cosmetics and beauty Heathcare—16 Dec 20

The second phase of IP Key SEA's #YourHealthIsPriceless campaign has been launched to raise awareness among consumers about the harm that counterfeit cosmetics can cause to their face, skin, and holistic well-being. Today, the IP Key South-East Asia

ADC Therapeutics and Overland Pharma Form Strategic JV to Expand ADC Drugs Development and Heathcare—16 Dec 20

M.S.Q. Ventures ("MSQ") is pleased to announce that its client, ADC Therapeutics SA (NYSE: ADCT), has successfully entered into an agreement to jointly form a new company, Overland ADCT BioPharma (CY) Limited with Overland Pharmaceuticals, a fully

AIDA Cruises uses temperature detection by DERMALOG Heathcare—16 Dec 20

AIDA Cruises has implemented the contactless Body Temperature Camera from the German company DERMALOG as part of its health and hygiene concept. DERMALOG's solution measures body temperature in real-time using state-of-the-art sensor technology. If an

Sai Life Sciences releases its first Sustainability Report Heathcare—15 Dec 20

- Highlights the various sustainable choices embraced by the company in steering its journey on a sustainable path Sai Life Sciences, one of India's fastest growing Contract Research, Development & Manufacturing Organizations (CRO/ CDMO), today

Innovations for Thai Lung Cancer Patients 2020 launch "LungAndMe" Heathcare—14 Dec 20

Innovations for Thai Lung Cancer Patients 2020: evolving treatments for lung cancerBringing greater convenience to patients with the launch of "LungAndMe" Every November marks the annual Lung Cancer Awareness Month, where countries around the world,